Table 2:
Sleep Parameters on Intervention Nights
Placebo vs. Suvorexant 10 mg | Placebo vs. Suvorexant 20 mg | |
---|---|---|
NIGHT 1 | ||
Total Sleep Time (min) | ||
Mean difference | −34.88 | −50.47 |
95% CI | −97.77, 28.00 | −114.6, 13.71 |
p-value | 0.35 | 0.14 |
Sleep Efficiency (%) | ||
Mean difference | −3.94 | −7.65 |
95% CI | −11.91, 4.04 | −15.79, 0.49 |
p-value | 0.43 | 0.07 |
NREM Stage 2 (min) | ||
Mean difference | −21.73 | −25.71 |
95% CI | −79.59, 36.13 | −84.77, 33.34 |
p-value | 0.60 | 0.51 |
NREM Stage 3 (min) | ||
Mean difference | −17.35 | −11.27 |
95% CI | −54.99, 20.30 | −49.69, 27.15 |
p-value | 0.47 | 0.73 |
REM (min) | ||
Mean difference | −5.50 | −20.96 |
95% CI | −48.38, 37.38 | −64.73, 22.80 |
p-value | 0.94 | 0.45 |
NIGHT 2 | ||
Total Sleep Time (min) | ||
Mean difference | −10.54 | −38.71 |
95% CI | −88.42, 67.33 | −116.6, 39.17 |
p-value | 0.93 | 0.42 |
Sleep Efficiency (%) | ||
Mean difference | −0.10 | −5.26 |
95% CI | −10.39, 10.19 | −15.55, 5.03 |
p-value | 0.99 | 0.40 |
NREM Stage 2 (min) | ||
Mean difference | −0.43 | −9.89 |
95% CI | −61.92, 61.07 | −71.38, 51.61 |
p-value | 0.99 | 0.91 |
NREM Stage 3 (min) | ||
Mean difference | −10.90 | −3.49 |
95% CI | −52.16, 30.36 | −44.75, 37.77 |
p-value | 0.77 | 0.97 |
REM (min) | ||
Mean difference | −2.30 | −21.46 |
95% CI | −36.68, 32.09 | −55.85, 12.93 |
p-value | 0.98 | 0.27 |
Mg: milligrams; min: minutes; CI: confidence intervals; NREM: non-rapid eye movement; REM: rapid eye movement.
p-values corrected using Dunnett’s multiple comparison’s test